| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue and operating profit grew together, indicating healthy core operations.
Operating margin improved by 3.51 percentage points year over year.
- Revenue
- USD 10.65B YoY +9.48%
- Largest revenue segment share (Interventional Cardiology Therapies)
- 24.21% YoY +0.53pp
- Selling, general and administrative
- USD 3.58B Share 33.66% · YoY +8.18%
- Cost of revenue
- USD 3.18B Share 29.91% · YoY +3.04%
View calculation evidence
YoY periods: H1 2026 compared with H1 2025
Source metrics
- RevenueNet sales · RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenueCost of products sold (excluding amortization expense) · CostOfGoodsAndServicesSold
- Selling, general and administrativeSelling, general and administrative expenses · SellingGeneralAndAdministrativeExpense
- Largest revenue segment share (Interventional Cardiology Therapies)Interventional Cardiology Therapies · segment_value / revenue * 100
- Operating marginOperating income (loss) · operating_income / revenue * 100